These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12118241)

  • 21. In vitro selection of allosteric ribozymes: theory and experimental validation.
    Piganeau N; Thuillier V; Famulok M
    J Mol Biol; 2001 Oct; 312(5):1177-90. PubMed ID: 11580234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photochemical hammerhead ribozyme activation.
    Young DD; Deiters A
    Bioorg Med Chem Lett; 2006 May; 16(10):2658-61. PubMed ID: 16513347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concerted effects of two activator modules on the group I ribozyme reaction.
    Ikawa Y; Shiohara T; Ohuchi S; Inoue T
    J Biochem; 2009 Apr; 145(4):429-35. PubMed ID: 19122204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineered allosteric ribozymes that respond to specific divalent metal ions.
    Zivarts M; Liu Y; Breaker RR
    Nucleic Acids Res; 2005; 33(2):622-31. PubMed ID: 15681614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly active low magnesium hammerhead ribozyme.
    Fedoruk-Wyszomirska A; Szymański M; Wyszko E; Barciszewska MZ; Barciszewski J
    J Biochem; 2009 Apr; 145(4):451-9. PubMed ID: 19124457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probing general base catalysis in the hammerhead ribozyme.
    Thomas JM; Perrin DM
    J Am Chem Soc; 2008 Nov; 130(46):15467-75. PubMed ID: 18950173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rational design of allosteric ribozymes.
    Tang J; Breaker RR
    Chem Biol; 1997 Jun; 4(6):453-9. PubMed ID: 9224568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro selection of adenine-dependent ribozyme against Tpl2/Cot oncogene.
    Li YL; Vergne J; Torchet C; Maurel MC
    FEBS J; 2009 Jan; 276(1):303-14. PubMed ID: 19054068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A tale in molecular recognition: the hammerhead ribozyme.
    Westhof E
    J Mol Recognit; 2007; 20(1):1-3. PubMed ID: 17089350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A genomewide search for ribozymes reveals an HDV-like sequence in the human CPEB3 gene.
    Salehi-Ashtiani K; Lupták A; Litovchick A; Szostak JW
    Science; 2006 Sep; 313(5794):1788-92. PubMed ID: 16990549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineering high-speed allosteric hammerhead ribozymes.
    Link KH; Guo L; Ames TD; Yen L; Mulligan RC; Breaker RR
    Biol Chem; 2007 Aug; 388(8):779-86. PubMed ID: 17655496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High hydrostatic pressure approach proves RNA catalytic activity without magnesium.
    Fedoruk-Wyszomirska A; Wyszko E; Giel-Pietraszuk M; Barciszewska MZ; Barciszewski J
    Int J Biol Macromol; 2007 Jun; 41(1):30-5. PubMed ID: 17222901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catalytic strategies of self-cleaving ribozymes.
    Cochrane JC; Strobel SA
    Acc Chem Res; 2008 Aug; 41(8):1027-35. PubMed ID: 18652494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational design and experimental validation of oligonucleotide-sensing allosteric ribozymes.
    Penchovsky R; Breaker RR
    Nat Biotechnol; 2005 Nov; 23(11):1424-33. PubMed ID: 16244657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An allosteric hammerhead ribozyme.
    Porta H; Lizardi PM
    Biotechnology (N Y); 1995 Feb; 13(2):161-4. PubMed ID: 9634757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New insights into the catalytic activation of the MAPK phosphatase PAC-1 induced by its substrate MAPK ERK2 binding.
    Zhang Q; Muller M; Chen CH; Zeng L; Farooq A; Zhou MM
    J Mol Biol; 2005 Dec; 354(4):777-88. PubMed ID: 16288922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative single-turnover kinetic analyses of trans-cleaving hammerhead ribozymes with naturally derived non-conserved sequence motifs.
    Weinberg MS; Rossi JJ
    FEBS Lett; 2005 Mar; 579(7):1619-24. PubMed ID: 15757651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-synthetically ligated ribozymes: an alternative approach to iterative solid-phase synthesis.
    Bellon L; Workman CT; Jarvis TC; Wincott FE
    Bioconjug Chem; 1997; 8(2):204-12. PubMed ID: 9095362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Docking interactions induce exposure of activation loop in the MAP kinase ERK2.
    Zhou T; Sun L; Humphreys J; Goldsmith EJ
    Structure; 2006 Jun; 14(6):1011-9. PubMed ID: 16765894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A conformational switch controls hepatitis delta virus ribozyme catalysis.
    Ke A; Zhou K; Ding F; Cate JH; Doudna JA
    Nature; 2004 May; 429(6988):201-5. PubMed ID: 15141216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.